The Chancellor, Masters, Scholars Of The University Of Cambridge investment portfolio

Cambivac Ltd conducts research and development of vaccines and antiviral agents, leading molecular virology programmes and creating antiviral drugs for respiratory diseases in pigs and poultry.

Enval develops recycling and environmental technology that converts previously unrecyclable flexible and multilayer plastic packaging into valuable, endlessly recyclable material. Its modular solution is designed for deployment at various sites to serve waste‑management and packaging industries.